Sprint Interval Training for Endurance Performance
What You Need to Know Before You Apply
What is the purpose of this trial?
Sprint interval training improves endurance performance and induces metabolic adaptations in muscle. Most research demonstrating these responses has been conducted in males, with limited studies evaluating changes to endurance performance and skeletal muscle oxidative capacity in females. Moreover, it is currently unknown if training in specific phases of the menstrual cycle influences adaptations to training. Thus, the purpose of the present study is to compare adaptations to 2 weeks of sprint interval training performed in the follicular vs. luteal phase of the menstrual cycle in healthy, eumenorrheic women.
Will I have to stop taking my current medications?
Yes, you will need to stop taking medications that affect blood glucose, lipid metabolism, or substrate metabolism, such as corticosteroids or NSAIDs, to participate in this trial.
Is sprint interval training generally safe for humans?
How does the treatment Sprint Interval Training differ from other treatments for endurance performance?
Sprint Interval Training (SIT) is unique because it involves short, intense bursts of exercise followed by rest, which can improve both aerobic and anaerobic performance with less time commitment compared to traditional endurance training. This makes it a time-efficient option for enhancing endurance and strength, especially for those with limited time for exercise.678910
What data supports the effectiveness of the treatment Sprint Interval Training for endurance performance?
Research shows that Sprint Interval Training (SIT) can improve physical performance, including endurance, by a moderate amount in a short time. Studies found that SIT can enhance running performance and endurance adaptations, especially when combined with active recovery, making it a time-efficient alternative to traditional endurance training.611121314
Are You a Good Fit for This Trial?
This trial is for healthy, active women with a consistent menstrual cycle of 27-35 days and minimal variability. They should be non-smokers, engage in regular exercise (2-4 times per week), have a BMI of 18-27 kg/m2, and show evidence of ovulation. Women who don't meet these physical activity levels or menstrual cycle criteria cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform 6 sessions of sprint interval training over 2 weeks in either the Follicular Phase or Luteal Phase of their menstrual cycle
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Sprint Interval Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor